Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 151, Issue -, Pages 113127
Publisher
Elsevier BV
Online
2022-05-20
DOI
10.1016/j.biopha.2022.113127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats
- (2022) Zakiah N. Almohawes et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway
- (2022) Tingyi Du et al. Metabolites
- Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
- (2022) Tobias Puengel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism
- (2022) Hai-Yan Ni et al. PHYTOMEDICINE
- Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors
- (2021) Marica Cariello et al. Cellular and Molecular Gastroenterology and Hepatology
- Crosstalk between PPARs and gut microbiota in NAFLD
- (2021) Liwei Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
- (2021) Haifa M. AlNafea et al. PPAR Research
- 18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice
- (2021) Yiming Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evodiamine Lowers Blood Lipids by Up-Regulating the PPARγ/ABCG1 Pathway in High-Fat-Diet-Fed Mice
- (2021) Xingming Hou et al. JOURNAL OF NATURAL PRODUCTS
- Regulation of lipid‐induced macrophage polarization through modulating PPAR‐γ activity affects hepatic lipid metabolism via TLR4/NF‐κB signaling pathway
- (2020) Hui‐Min Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Mohammad Zarei et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
- (2020) Yusuke Sasaki et al. Scientific Reports
- Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis
- (2020) L. Yahaghi et al. Physiology International
- Dehydroabietic acid alleviates high fat diet-induced insulin resistance and hepatic steatosis through dual activation of PPAR-γ and PPAR-α
- (2020) Zhishen Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?
- (2020) David H Ipsen et al. Advances in Nutrition
- Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
- (2020) Anne Fougerat et al. Cells
- Emerging role of Insig-1 in lipid metabolism and lipid disorders
- (2020) Shuhui Ouyang et al. CLINICA CHIMICA ACTA
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
- (2019) Lei Tong et al. Cell Death & Disease
- Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on Nonalcoholic Fatty Liver Disease through Activating the PPARα Signaling Pathway
- (2019) Xiao-Long Hu et al. PLANTA MEDICA
- Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway
- (2019) Yujie Huang et al. Applied Physiology Nutrition and Metabolism
- Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?
- (2019) Dong Yun Kim et al. Hepatobiliary Surgery and Nutrition
- Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment
- (2019) Sanne J. C. M. Frambach et al. PHARMACOLOGICAL REVIEWS
- Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression
- (2019) Lu Li et al. Redox Biology
- Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
- (2019) Tingting Yan et al. Acta Pharmaceutica Sinica B
- Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy
- (2019) Giovanni Tarantino et al. Journal of Clinical Medicine
- Activation of hepatic Nogo-B receptor expression—A new anti-liver steatosis mechanism of statins
- (2018) Wenwen Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Animal models of NAFLD from a hepatologist's point of view
- (2018) Daniel Jahn et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ
- (2018) Dongyang Li et al. BRITISH JOURNAL OF NUTRITION
- Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation
- (2018) Amanda Karolina Soares Silva et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway
- (2018) Xiaoxue Zhang et al. FREE RADICAL RESEARCH
- Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR signaling
- (2018) Juan Zhong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
- (2018) Xavier Palomer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ
- (2018) Xueqing Zhong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Phillyrin lowers body weight in obese mice via the modulation of PPAR/-ANGPTL 4 pathway
- (2018) Hong-Bo Xiao et al. Obesity Research & Clinical Practice
- Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
- (2018) Mohammad Zarei et al. Molecular Metabolism
- Mechanism of Action of Magnesium Lithospermate B against Aging and Obesity-Induced ER Stress, Insulin Resistance, and Inflammsome Formation in the Liver
- (2018) Ji Jeong et al. MOLECULES
- A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
- (2018) Josephine Skat-Rørdam et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH
- (2018) Geoff Farrell et al. HEPATOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Targeting nuclear receptors for the treatment of fatty liver disease
- (2017) Naoki Tanaka et al. PHARMACOLOGY & THERAPEUTICS
- Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease
- (2017) Wenjing Luo et al. Scientific Reports
- Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida
- (2017) Qin-Hu Sun et al. Scientific Reports
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- 5,7-Dihydroxy-6-geranylflavanone improves insulin sensitivity through PPARα/γ dual activation
- (2016) WOOJUNG LEE et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
- (2016) Abigail Wolf Greenstein et al. JOURNAL OF ENDOCRINOLOGY
- Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells
- (2016) Shumin Qin et al. LIPIDS
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice
- (2016) Hee-Sook Park et al. MOLECULAR NUTRITION & FOOD RESEARCH
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency
- (2016) Yu Zhang et al. Scientific Reports
- Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγin a Rat Model
- (2015) Warinda Susutlertpanya et al. Evidence-based Complementary and Alternative Medicine
- Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes
- (2015) OK-HWA KANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats
- (2015) Zhi-Gang Qi et al. PHARMACEUTICAL BIOLOGY
- Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
- (2015) Hyun Jung Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ
- (2014) Xiujing Feng et al. BIOCHEMICAL PHARMACOLOGY
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- (2014) Michal Pawlak et al. HEPATOLOGY
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- γ-Mangostin fromGarcinia MangostanaPericarps as a Dual Agonist That Activates Both PPARα and PPARδ
- (2013) Nobuyasu MATSUURA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1
- (2013) Nasrin Ziamajidi et al. FOOD AND CHEMICAL TOXICOLOGY
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
- (2013) Akinobu Takaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
- (2013) Francisco A. Monsalve et al. MEDIATORS OF INFLAMMATION
- Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ
- (2013) Yuri Sakamoto et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Ombuin-3-O-β-d-glucopyranoside from Gynostemma pentaphyllum is a dual agonistic ligand of peroxisome proliferator-activated receptors α and δ/β
- (2012) Mastura Abd Malek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism
- (2011) Yaoyao Jia et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AMP-activated protein kinase and its downstream transcriptional pathways
- (2010) Carles Cantó et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- PPARγ is essential for protection against nonalcoholic steatohepatitis
- (2010) C W Wu et al. GENE THERAPY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro
- (2010) Jun Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα
- (2010) Jonathan Goldwasser et al. PLoS One
- Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
- (2008) Elizabeth E. Girroir et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin Sensitivity
- (2008) Kihwa Kang et al. Cell Metabolism
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
- (2008) Eric R Kallwitz et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
- (2007) Philip J. Barter et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The PPARα-PGC-1αAxis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
- (2007) Jennifer G. Duncan et al. PPAR Research
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started